These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Overnight urinary uric acid: creatinine ratio for detection of sleep hypoxemia. Validation study in chronic obstructive pulmonary disease and obstructive sleep apnea before and after treatment with nasal continuous positive airway pressure. Braghiroli A; Sacco C; Erbetta M; Ruga V; Donner CF Am Rev Respir Dis; 1993 Jul; 148(1):173-8. PubMed ID: 8317794 [TBL] [Abstract][Full Text] [Related]
4. Continuous positive airway pressure for sleep-related breathing disorders in multiple system atrophy: long-term acceptance. Ghorayeb I; Yekhlef F; Bioulac B; Tison F Sleep Med; 2005 Jul; 6(4):359-62. PubMed ID: 15978519 [TBL] [Abstract][Full Text] [Related]
5. Treatment of obstructive sleep apnea syndrome with nasal continuous positive airway pressure. McEvoy RD; Thornton AT Sleep; 1984; 7(4):313-25. PubMed ID: 6440264 [TBL] [Abstract][Full Text] [Related]
12. Long-term evolution of daytime somnolence in patients with sleep apnea/hypopnea syndrome treated by continuous positive airway pressure. Meurice JC; Paquereau J; Neau JP; Caron F; Dore P; Ingrand P; Patte F Sleep; 1997 Dec; 20(12):1162-6. PubMed ID: 9493927 [TBL] [Abstract][Full Text] [Related]
13. The use of auto-titrating continuous positive airway pressure for treatment of adult obstructive sleep apnea. An American Academy of Sleep Medicine review. Berry RB; Parish JM; Hartse KM Sleep; 2002 Mar; 25(2):148-73. PubMed ID: 11902425 [TBL] [Abstract][Full Text] [Related]
14. An evaluation of long-term nasal CPAP therapy for sleep apnea. Hsu RW; Huang WL; King SL; Chiang CD Zhonghua Yi Xue Za Zhi (Taipei); 1992 Oct; 50(4):293-6. PubMed ID: 1334787 [TBL] [Abstract][Full Text] [Related]
15. Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. McArdle N; Devereux G; Heidarnejad H; Engleman HM; Mackay TW; Douglas NJ Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1108-14. PubMed ID: 10194153 [TBL] [Abstract][Full Text] [Related]
16. [Nasal CPAP therapy of obstructive sleep apnea syndrome with expiratory pressure reduction: a prospective randomized study of acceptance of treatment during therapy initiation]. Ficker JH; Müller D; Wiest G; Lehnert G; Dertinger SH; Katalinic A; Hahn EG Pneumologie; 1997 Jun; 51(6):586-91. PubMed ID: 9333792 [TBL] [Abstract][Full Text] [Related]
17. Objective measurement of compliance with nasal CPAP treatment for obstructive sleep apnoea syndrome. Krieger J; Kurtz D Eur Respir J; 1988 May; 1(5):436-8. PubMed ID: 3049136 [TBL] [Abstract][Full Text] [Related]
18. Treatment of obstructive sleep apnea with nasal continuous positive airway pressure. Patient compliance, perception of benefits, and side effects. Hoffstein V; Viner S; Mateika S; Conway J Am Rev Respir Dis; 1992 Apr; 145(4 Pt 1):841-5. PubMed ID: 1554212 [TBL] [Abstract][Full Text] [Related]
19. Nasal continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea in Hallermann-Streiff syndrome. Ryan CF; Lowe AA; Fleetham JA Clin Pediatr (Phila); 1990 Feb; 29(2):122-4. PubMed ID: 2406080 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of treatment choices for snoring and sleep apnea in an Australian population. Marshall NS; Bartlett DJ; Matharu KS; Williams A; Grunstein RR J Clin Sleep Med; 2007 Dec; 3(7):695-9. PubMed ID: 18198802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]